Modular Medical, Inc. MODD
We take great care to ensure that the data presented and summarized in this overview for Modular Medical, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding MODD
View all-
Solas Capital Management, LLC Darien, CT1.88MShares$3.2 Million3.38% of portfolio
-
683 Capital Management, LLC New York, NY1.52MShares$2.58 Million0.31% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.5MShares$2.56 Million0.0% of portfolio
-
Bard Associates Inc Chicago, IL1.46MShares$2.49 Million1.23% of portfolio
-
Silverarc Capital Management, LLC1.44MShares$2.45 Million0.81% of portfolio
-
Bleichroeder LP New York, NY900KShares$1.53 Million0.68% of portfolio
-
Awm Investment Company, Inc. New York, NY750KShares$1.28 Million0.23% of portfolio
-
Corsair Capital Management, L.P. New York, NY537KShares$913,5170.3% of portfolio
-
Geode Capital Management, LLC Boston, MA306KShares$520,9480.0% of portfolio
-
Bank Of Montreal Toronto, A6201KShares$342,0400.0% of portfolio
Latest Institutional Activity in MODD
Top Purchases
Top Sells
About MODD
Modular Medical, Inc., a development stage medical device company, focuses on the design, development, and commercialization of insulin pumps using technology to enhance pump adoption in the diabetes marketplace. The company is headquartered in San Diego, California.
Insider Transactions at MODD
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 03
2024
|
Manchester Management CO LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
21,000
+7.32%
|
$21,000
$1.68 P/Share
|
Nov 27
2024
|
Manchester Management CO LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
100,000
+29.01%
|
$100,000
$1.69 P/Share
|
Nov 21
2024
|
Manchester Management CO LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
166,666
+4.83%
|
$166,666
$1.5 P/Share
|
Sep 30
2024
|
Carmen B Volkart Director |
BUY
Grant, award, or other acquisition
|
Direct |
625
+5.45%
|
-
|
Sep 30
2024
|
Steven G Felsher Director |
BUY
Grant, award, or other acquisition
|
Direct |
750
+0.58%
|
-
|
Sep 30
2024
|
Duane M De Sisto Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+0.94%
|
-
|
Aug 19
2024
|
Philip Brent Sheibley Director |
BUY
Open market or private purchase
|
Direct |
15,000
+18.49%
|
$15,000
$1.69 P/Share
|
Jun 28
2024
|
Duane M De Sisto Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+0.95%
|
-
|
Jun 28
2024
|
Steven G Felsher Director |
BUY
Grant, award, or other acquisition
|
Direct |
750
+0.59%
|
-
|
Jun 28
2024
|
Carmen B Volkart Director |
BUY
Grant, award, or other acquisition
|
Direct |
625
+5.77%
|
-
|
Mar 29
2024
|
Steven G Felsher Director |
BUY
Grant, award, or other acquisition
|
Direct |
750
+0.59%
|
-
|
Mar 29
2024
|
Carmen B Volkart Director |
BUY
Grant, award, or other acquisition
|
Direct |
625
+6.12%
|
-
|
Mar 29
2024
|
Duane M De Sisto Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+3.45%
|
-
|
Mar 29
2024
|
Philip Brent Sheibley Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+4.66%
|
-
|
Feb 16
2024
|
Manchester Management CO LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
900,000
+22.4%
|
$900,000
$1.1 P/Share
|
Dec 29
2023
|
Philip Brent Sheibley Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+4.89%
|
-
|
Dec 29
2023
|
Duane M De Sisto Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+5.1%
|
-
|
Dec 29
2023
|
Steven G Felsher Director |
BUY
Grant, award, or other acquisition
|
Direct |
750
+0.59%
|
-
|
Dec 29
2023
|
Carmen B Volkart Director |
BUY
Grant, award, or other acquisition
|
Direct |
625
+6.52%
|
-
|
Nov 01
2023
|
Philip Brent Sheibley Director |
BUY
Open market or private purchase
|
Direct |
10,000
+17.81%
|
$10,000
$1.29 P/Share
|
Last 12 Months Summary
Grant, award, or other acquisition | 20.5K shares |
---|---|
Open market or private purchase | 1.2M shares |